Celyad Oncology (CLYYF) Stock Price, Quote, News & History

Comments

Celyad Oncology SA (CLYYF) Stock Price, Quote, News & History

CLYYFOTCEM

Trade with Public

$0.3500

Last update: Mar 6, 3:01 PM

OverviewNews Short Interest

Key Statistics

Open

Volume / Avg.

0 / 600.00

Day Range

- - -

52 Wk Range

0.15 - 0.53

Market Cap

$15.67M

P/E Ratio

16.68

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

11.71

Recent Celyad Oncology SA News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-6.90M

Investing Cash Flow (TTM)

3.01M

Financing Cash Flow (TTM)

1.39M

Free Cash Flow (TTM)

-6.90M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-2.50M

Valuation Metrics

Enterprise Value

$14.96M

PE Ratio (TTM)

16.68

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

659.19

PB Ratio (TTM)

5.51

Earnings Yield % (TTM)

6.00%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

12.00

Price / EBITDA (TTM)

12.99

Price / Free Cash Flow (TTM)

Book Value / Share

$0.06

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$4.98M

Debt to Equity

0.53

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

0 / 600.00

Day Range

- - -

52 Wk Range

0.15 - 0.53

Market Cap

$15.67M

P/E Ratio

16.68

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

11.71

About

Sector

Health Care

Industry

Biotechnology

Celyad Oncology SA is a biopharmaceutical company focused on the discovery and development of technologies for chimeric antigen receptor T-cell (CAR T) therapies. The company focuses on solid tumors and hematological malignancies. The firm has CYAD-0...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Celyad Oncology (CLYYF) stock?

You can purchase shares of Celyad Oncology (OTCEM:CLYYF) through any online brokerage.

View our list of the best stock brokerages

Who are Celyad Oncology (CLYYF) competitors?

There are no as such competitors for Celyad Oncology.

What is the forecast, or price target, for Celyad Oncology (CLYYF) stock?

There is no analysis for Celyad Oncology to provide a consensus price target.

What is the current price for Celyad Oncology (CLYYF)?

The stock price for Celyad Oncology (OTCEM: CLYYF) is $0.35 last updated March 6, 2026 at 3:01 PM EST.

Does Celyad Oncology (CLYYF) pay a dividend?

There are no upcoming dividends for Celyad Oncology.

When is Celyad Oncology (OTCEM:CLYYF) reporting earnings?

Celyad Oncology does not have any upcoming earnings scheduled.

Is Celyad Oncology (CLYYF) going to split?

There is no upcoming split for Celyad Oncology.

What sector and industry does Celyad Oncology (CLYYF) operate in?

Celyad Oncology is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.

Key Statistics

Open

Volume / Avg.

0 / 600.00

Day Range

- - -

52 Wk Range

0.15 - 0.53

Market Cap

$15.67M

P/E Ratio

16.68

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

11.71

Recent Celyad Oncology SA News

No news found